877 related articles for article (PubMed ID: 7657807)
1. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
3. Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma.
Radka SF; Nakamura S; Sakurada S; Salahuddin SZ
J Immunol; 1993 Jun; 150(11):5195-201. PubMed ID: 8098726
[TBL] [Abstract][Full Text] [Related]
4. Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis.
Stürzl M; Brandstetter H; Zietz C; Eisenburg B; Raivich G; Gearing DP; Brockmeyer NH; Hofschneider PH
Oncogene; 1995 May; 10(10):2007-16. PubMed ID: 7761101
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S
J Immunol; 1997 Jun; 158(11):5518-26. PubMed ID: 9164976
[TBL] [Abstract][Full Text] [Related]
7. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M is a differentiation factor for myeloid leukemia cells.
Bruce AG; Hoggatt IH; Rose TM
J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
[TBL] [Abstract][Full Text] [Related]
10. A ciliary neurotrophic factor-sensitive human myeloma cell line.
Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
[TBL] [Abstract][Full Text] [Related]
11. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
Hui W; Bell M; Carroll G
Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
[TBL] [Abstract][Full Text] [Related]
12. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
13. Expression of interleukin-6 receptors and NF-kappa B in AIDS-related Kaposi sarcoma cell strains.
Bailer RT; Ng-Bautista CL; Ness GM; Mallery SR
Lymphology; 1997 Jun; 30(2):63-76. PubMed ID: 9215976
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
Gearing DP; Bruce AG
New Biol; 1992 Jan; 4(1):61-5. PubMed ID: 1536831
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
16. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
Malaval L; Liu F; Vernallis AB; Aubin JE
J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
[TBL] [Abstract][Full Text] [Related]
17. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
18. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.
Murakami-Mori K; Mori S; Nakamura S
J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033
[TBL] [Abstract][Full Text] [Related]
19. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
20. Specific binding of leukemia inhibitory factor to murine myoblasts in culture.
Bower J; Vakakis N; Nicola NA; Austin L
J Cell Physiol; 1995 Jul; 164(1):93-8. PubMed ID: 7790402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
